Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
מצבים רפואיים
Bipolar I Disorder
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Pillar Clinical Research, Bentonville, Arkansas, United States
Pillar Clinical Research, Little Rock, Arkansas, United States
CenExel, Bellflower, California, United States
ProScience Research Group, Culver City, California, United States
CenExel, Garden Grove, California, United States
Synergy San Diego, Lemon Grove, California, United States
NRC Research Institute, Los Angeles, California, United States
NRC Research Institute, Orange, California, United States
CenExel, Riverside, California, United States
CenExel, Torrance, California, United States
St. Jude Clinical Research, Doral, Florida, United States
Cenexel Hollywood Florida, Hollywood, Florida, United States
Innovative Clinical Research, Miami Lakes, Florida, United States
Health Synergy Clinical Research, West Palm Beach, Florida, United States
Trialmed, Atlanta, Georgia, United States
Cenexel Decatur GA, Decatur, Georgia, United States
Pillar Clinical Research, Chicago, Illinois, United States
NSRT, Detroit, Michigan, United States
Arch Clinical Trials, St Louis, Missouri, United States
Redbird Research, Las Vegas, Nevada, United States
Manhattan Behavioral Medicine, New York, New York, United States
Neuro-Behavioral Clinical Research, Canton, Ohio, United States
Adams Clinical, Philadelphia, Pennsylvania, United States
Adams Clinical, DeSoto, Texas, United States
Pillar Clinical Research, Richardson, Texas, United States
Northwest Clinical Research Center, Bellevue, Washington, United States